Proposed legislation would regulate use of antipsychotics in nursing home residents

Share this article:
Sen. Herb Kohl (D-WI)
Sen. Herb Kohl (D-WI)

Three Senators have proposed legislation that would further regulate the administration of antipsychotic medications to nursing home residents.

The bipartisan bill, proposed Tuesday, would require nursing home staff to obtain informed consent from a resident or their legally designated representative acknowledging the potential risks and side effects associated with the antipsychotic medications. These prescription medications often are prescribed to elderly nursing home residents who experience aggressive or agitated behavior as a result of Alzheimer's or other forms of dementia.

The bill is an amendment to an existing Food and Drug Administration bill, S. 3187 and proposed by Sens. Herb Kohl (D-WI), Chuck Grassley, (R-IA) and Richard Blumenthal, (D-CT). It addresses growing concern about the safety of prescribing antipsychotics for “off label” use. Medications such as Risperdal and Haloperidol are only officially approved to treat mental illnesses such as schizophrenia.

“This amendment responds to alarming reports about the use of antipsychotic drugs with nursing home residents,” Grassley said in a statement. “It's intended to empower these residents and their loved ones in the decisions about the drugs prescribed for them.”

The legislation also follows a 2011 Office of the Inspector General report that uncovered widespread overuse of these medications in nursing homes despite “black box” warnings about them from the FDA. That report stated that more than half of the 1.4 million claims for atypical antipsychotic drugs totaled $116.5 million and did not comply with Medicare reimbursement criteria.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...